Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

PGEN stock hub

Precigen, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PGENis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.5B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

PGEN

In the news

Latest news · PGEN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-572

P25 -105.6P50 -46.5P75 -3.1

ROIC-69.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PGEN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001356090
Company name	Precigen, Inc.
Country	United States
Country code	US
Cusip	74017N105
Employees	160
Employees Change	17%
Employees Change Percent	11.89
Enterprise value	$1.5B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US74017N1054
Last refreshed	2026-05-10
Market cap	$1.5B
Market cap category	Small-Cap
Price	$4.21
Price currency	USD
Rev Per Employee	60,525x
Sector	Healthcare
Sic	2834
Symbol	PGEN
Website	https://precigen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-28.83%
EV Sales Forward	12.66x
EV/Sales	153.91x
FCF yield	-6.03%
P/B ratio	71.25x
P/S ratio	153.87x
PS Forward	12.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-36.5M
Net Income	$-429.6M
Net Income Growth Years	0%
Pretax Margin	-2,588.18%
Profit Per Employee	$-2.7M
ROA	-44.3
Roa5y	-29.54
ROCE	-90.19
ROE	-572
Roe5y	-196.4
ROIC	-69.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-16.71%
Cagr1y	212.1%
Cagr3y	51.1%
Cagr5y	-8.43%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	146.73x
Revenue Growth Q	283.61x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	-28.87x
Revenue Growth5 Y	-21.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.06
Assets	$155.5M
Cash	$97.9M
Current Assets	$115.2M
Current Liabilities	$37.3M
Debt	$98.3M
Debt Equity	$4.7
Equity	$20.9M
Interest Coverage	-27.57
Liabilities	$134.6M
Long Term Assets	$40.3M
Long Term Liabilities	$97.3M
Net Cash	$-432,000
Net Cash By Market Cap	$-0.03
Net Debt Equity	$0.02
Tangible Book Value	$2.5M
Tangible Book Value Per Share	$0.01
WACC	9.69

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.09
Net Working Capital	$-18.8M
Quick ratio	2.74
Working Capital	$77.9M
Working Capital Turnover	$0.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.9%
Dividend per share	$0
Dividend Yield	0%
Last Dividend	$0.16

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-83.94%
1Y total return	211.85%
200-day SMA	3.81
3Y total return	245.08%
50-day SMA	3.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-35.63%
All Time High	69.45
All Time High Change	-93.94%
All Time High Date	2015-08-06
All Time Low	0.65
All Time Low Change	546.4%
All Time Low Date	2024-12-16
ATR	0.23
Beta	1.07
Beta1y	1.02
Beta2y	1.69
Ch YTD	0.72
High	4.24
High52	5.47
High52 Date	2026-02-17
High52ch	-22.96%
Low	4.11
Low52	1.23
Low52 Date	2025-05-08
Low52ch	243.67%
Ma50ch	10.94%
Premarket Change Percent	1.69
Premarket Price	$4.22
Premarket Volume	580
Price vs 200-day SMA	10.61%
RSI	55.12
RSI Monthly	62.26
RSI Weekly	54.19
Sharpe ratio	1.52x
Sortino ratio	3.22
Total Return	-16.9%
Tr YTD	0.72
Tr1m	2.18%
Tr1w	3.19%
Tr3m	-1.86%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	1
Analyst Price Target Top	$6
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.04
Earnings Revenue Estimate	20,868,000x
Earnings Revenue Estimate Growth	1,456.15x
Operating Income	$-106.6M
Operating margin	-1,100.8
Price target	$8.33
Price Target Change	$97.86
Price Target Change Top	$42.52

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	168,880,265%
Float Percent	47.72%
Net Borrowing	92,818,000
Shares Insiders	11.89%
Shares Institutions	34.97%
Shares Out	353,928,672
Shares Qo Q	15.34%
Shares Yo Y	16.9%
Short Float	23.56%
Short Ratio	7.09
Short Shares	11.24

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-101.2M
Average Volume	2,922,561.15x
Bv Per Share	0.06
CAPEX	$-2M
Ch10y	-83.94
Ch1m	2.18
Ch1w	3.19
Ch1y	211.9
Ch3m	-1.86
Ch3y	245.1
Ch5y	-35.63
Ch6m	7.95
Change	1.45%
Change From Open	0.72
Close	4.15
Days Gap	0.72
Depreciation Amortization	3,199,000
Dollar Volume	20,517,456.1
Earnings Date	2026-05-13
Earnings Time	amc
EBIT	$-106.6M
EBITDA	$-103.4M
EPS	$-1.37
F Score	3
FCF	$-89.8M
FCF EV Yield	-6.03x
FCF Per Share	$-0.25
Financing CF	90,048,000
Fiscal Year End	December
Founded	1,998
Goodwill	15,232,000
Income Tax	$3,000
Investing CF	-1,535,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-25
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-25
Ma150	4.01
Ma150ch	4.96%
Ma20	4.09
Ma20ch	3.06%
Net CF	717,000
Next Earnings Date	2026-05-13
Open	4.18
Optionable	Yes
Position In Range	76.92
Post Close	4.21
Postmarket Change Percent	-1.43
Postmarket Price	$4.15
Ppne	18,437,000
Pre Close	4.15
Price Date	2026-05-08
Ptbv Ratio	596.7
Relative Volume	1.67x
Revenue	9,684,000x
SBC By Revenue	117.65x
Share Based Comp	11,393,000
Tax By Revenue	0.03x
Tr6m	7.95%
Us State	Maryland
Volume	4,873,505
Z Score	-19.32

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does PGEN pay a dividend?

Capital-return profile for this ticker.

Performance

PGEN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns PGEN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+35.0%

Float: +47.7% of shares outstanding

Insider ownership

+11.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

PGEN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.1

Neutral momentum band

Price vs 200-day MA

+10.6%

50/200-day relationship not available

Beta (5Y)

1.07

Moves roughly with the market

Sharpe ratio

1.52

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PGEN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PGEN stock rating?

Precigen, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PGEN analysis?

The full report lives at /stocks/PGEN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PGEN?

The latest report frames PGEN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PGEN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.